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Here we demonstrate that natural variants of the yeast
Saccharomyces cerevisiae are a model system for the
systematic study of complex traits, specifically the re-
sponse to small molecules. As a complement to artifi-
cial knockout collections of S. cerevisiae widely used
to study individual gene function, we used 314- and
1932-member libraries of mutant strains generated
by meiotic recombination to study the cumulative,
quantitative effects of natural mutations on pheno-
types induced by 23 small-molecule perturbagens
(SMPs). This approach reveals synthetic lethality be-
tween SMPs, and genetic mapping studies confirm
the involvement of multiple quantitative trait loci in
the response to two SMPs that affect respiratory pro-
cesses. The systematic combination of natural vari-
ants of yeast and small molecules that modulate evo-
lutionarily conserved cellular processes can enable
a better understanding of the general features of com-
plex traits.
Introduction
The extensive use of artificial single-gene knockout col-
lections of the budding yeast Saccharomyces cerevisiae
[1] over the last decade has substantially increased our
knowledge of conserved eukaryotic cellular processes.
Although the use of gene-deletion collections simplifies
the tedious process of matching a mutation to an ob-
served phenotype, it only permits the study of the ef-
fects of deleting single genes or pairs of genes [2], as
opposed to combinations of loss- and gain-of-function
alleles of multiple genes. Most genetic traits are com-
plex (i.e., are encoded by allelic variants of at least two
different genes whose individual contributions have
graded effects, varying from small to large) [3–5]. In
this study, we build on the base of gene-deletion collec-
tions by using natural genetic variation, as opposed to
*Correspondence: stuart_schreiber@harvard.eduartificial mutations, in yeast as a means to study com-
plex traits—specifically, the response of cells (e.g., re-
sistance or sensitivity) to small molecules [6, 7]. The
use of small molecules to reveal complex traits was first
suggested by studies of metabolism in Neurospora over
60 years ago [8]. More recently, S. cerevisiae has been
exploited as a means to study global mRNA levels as
a complex trait, where cis- and trans-acting loci that her-
itably modulated the level of each transcript were iden-
tified [9, 10]. Another study has described quantitative
enological traits (e.g., ethanol tolerance) in wine-
making, industrial strains of yeast [11], among others
[12]. Now that the genome sequences of three variants
ofS. cerevisiae—a clinical isolate, an agricultural isolate,
and a common laboratory strain—are in hand, it will be
possible to identify tens of thousands of genetically en-
coded polymorphisms. However, whether these poly-
morphisms are functionally neutral or functionally active
is unknown. Here we show that small molecules can be
used systematically in yeast to link natural genetic vari-
ation to physiological phenotypes.
Results and Discussion
We identified 23 small-molecule perturbagens (SMPs)
(see Table S1 in the Supplemental Data available online)
that differentially inhibit the growth of one or more of
three diploid yeast strains that were the focus of an un-
related study to dissect the architecture of a quantitative
trait in yeast [13]: S1029, YAG040, and XHS123; a com-
monly used laboratory homozygous diploid, a clinical
isolate homozygous diploid derived over 20 years ago
from the lungs of an AIDS patient in San Francisco,
and the heterozygous diploid formed by crossing the
laboratory strain and the clinical isolate, respectively.
The genome sequence of a strain isogenic to YAG040
was recently sequenced [14], setting the stage for the
systematic characterization of polymorphisms between
it and the already-sequenced lab strain. XHS123 and
YAG040 were constructed with artificial dominant drug
resistance markers kanMX and hphMX, respectively,
both of which serve as standards of Mendelian, single-
gene traits.
The 23 SMPs are chemically diverse and differ in their
reported mechanisms of action, with the exception of
functional analogs, which will be further discussed be-
low. They are evenly divided between natural products
and synthetic products, and seven are Food and Drug
Administration (FDA)-approved drugs. Many have
been studied almost exclusively in the context of mam-
malian cells; for example, the central nervous system-
active compounds flunarizine and pimozide. These
SMPs are shown here to inhibit potently the growth of
yeast in a genotype-dependent and heritable manner.
We generated resistance/sensitivity profiles of two li-
braries (differing only in size) comprising 314 and 1932
random XHS123 meiotic segregants in order to charac-
terize the complexity of resistance or sensitivity to each
SMP at or near its IC50 concentration (Figure S1). Gener-
ally, growth inhibition by a small molecule segregates
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320Figure 1. Overview of the Generation and Pertubational Chemical Profiling of Random Meiotic Segregants of XHS123
(A) Two haploid yeast strains—in this study, derivatives of S1029 and YAG040—are mated in order to generate an F1 heterozygous diploid,
which was subsequently sporulated, yielding F1 segregants. Averaged, quantitative growth measurements of random segregants in multiple
conditions were arranged into a matrix and computationally analyzed.
(B) Segregation of two unlinked Mendelian traits illustrated by a heat map (red indicates saturating growth, or resistance; green indicates no
growth, or sensitivity) of clustered OD600 measurements of 314 XHS123 segregants grown in complete synthetic media lacking uracil (CSM-
URA); rich media containing 200 mg/ml G418; rich media containing 50 mg/ml flunarizine (SMP9). Half of XHS123 segregants were resistant to
G418, conferred by the kanMX cassette, but unable to grow without supplemental uracil, or vice versa. One-quarter of segregants were re-
sistant to both G418 and flunarizine; one-quarter were resistant to G418 but sensitive to flunarizine; one-quarter were sensitive to G418 but
resistant to flunarizine; one-quarter were sensitive to both G418 and flunarizine.
(C) Segregation of a single Mendelian trait illustrated by a heatmap of clustered OD600 measurements of 358 YAG040 segregants grown in rich
media containing 300 mg/ml of the antibiotic hygromycin B. Half of YAG040 segregants were resistant to hygromycin B, conferred by hphMX
cassette (i.e., were haploid); half were sensitive; that is, they inherited the wild-type copy of the HO gene, which enables self-diploidization (i.e.,
were diploid).
(D) Digital optical scan of clear-bottom, 384-well plate containing 366 random YAG040 segregants. Visual inspection of the number of wells
containing growth (192) versus those not containing growth (176) clearly indicates Mendelian segregation of hygromycin B resistance (192 re-
sistant/368 sensitive [52%]).either in a Mendelian (i.e., monogenic) or a complex (i.e.,
polygenic) fashion. As expected, the aforementioned
dominant drug resistance markers segregated as Men-
delian traits (Figures 1B and 1C). We next determined
whether growth inhibition by each SMP segregates in
a Mendelian or a complex fashion. As compared to the
control Mendelian trait, resistance to G418, which is
conferred by the kanMX cassette, growth inhibition by
all SMPs was found to be complex to varying degrees,
with the exception being flunarizine (SMP9) (Figure 2B),
a calcium ion (Ca2+) channel blocker [15], which ap-
peared to be a Mendelian trait at 48 hr postinoculation.Interestingly, however, at 72 hr, one-quarter of segre-
gants remained sensitive, while three-quarters became
resistant to flunarizine, suggesting a more complex
genetic underpinning to resistance: two sensitizing
alleles—one fast-acting (48 hr), the other slow-acting
(72 hr) (Figure 2B). In addition to being complex, growth
inhibition by the majority of SMPs also has a kinetic
component. The response to rapamycin (SMP45) exem-
plifies the variegated temporal and quantitative nature
of complex growth inhibition by a small molecule (Fig-
ure 2C). We also observed both Mendelian and complex
growth inhibition that was not induced by an SMP, but
Revealing Complex Traits with Small Molecules
321Figure 2. Rank-Ordered Distributions of
XHS123 Segregants Demonstrate that Growth
Inhibition by Small Molecules Is Polygenic, Ki-
netic, and Quantitative
(A) A total of 375 XHS123 MATa segregants
from the 1932 member library are plotted on
a 1D graph, where the x axis denotes the frac-
tion of the segregant population and the y
axis denotes normalized OD600 values: a =
rich media containing 200 mg/ml G418; b =
0.015% H2O2; c = 200 ng/ml tunicamycin
(SMP13); d = 25 mg/ml doxorubicin (SMP7).
Dashed vertical lines appear at 1/2, 3/4, 7/8,
and 15/16 marks.
(B) Rank-ordered distribution of 314 XHS123
segregants in 50 mg/ml flunarizine (SMP9).
The red curve corresponds to measurements
taken at 48 hr; the blue curve corresponds to
measurements taken at 72 hr. The chemical
structure of flunarizine appears in upper left
corner of the graph.
(C) Rank-ordered distribution of 314 XHS123
segregants in 500 ng/ml rapamycin (SMP45).
The red curve corresponds to measurements
taken at 48 hr; the blue curve corresponds to
measurements taken at 72 hr. The chemical
structure of rapamycin appears in the upper
left corner of the graph.rather by constituents of so-called stress media: rich
media containing 0.9 M sodium chloride (NaCl); syn-
thetic wine must (SWM), which combines osmotic and
pH shock; and growth on media containing maltose as
the sole carbon source (Figures S2A–S2C). Any non-
genetic variables (e.g., experimental noise or epigenetic
effects) play a minor role in our method, as revealed by
strong agreement between experimental replicates. Dis-
agreement between replicates is greatest at mid-log
phase OD600 values, as expected, as they would be
most sensitive to experimental variation (e.g., inoculum
size), while low and high OD600 values, corresponding to
hypersensitivity and resistance, are highly reproducible
(Figure S3).
We estimated the complexity of growth inhibition by
each SMP: the approximate number of genetic determi-
nants that underlie resistance (or sensitivity). The
ranked-order distributions of 375 MATa XHS123 segre-
gants in the presence of G418, H2O2, tunicamycin
(SMP13), and doxorubicin (SMP7) illustrate a series of
four complex traits underlain by increasing numbers
of genetic determinants (Figure 2A). The 375 MATa
XHS123 segregants comprise a portion of the 1932
member library, and were chosen to eliminate any pos-
sible confounding effects of ploidy. If we assume thatthe fraction of the resistant segregants approximates
1⁄2
n, where n equals the number of underlying genetic
determinants at a given kinetic snapshot and concentra-
tion, then a single gene underlies resistance to G418,
two underlie resistance to H2O2, three underlie resis-
tance to tunicamycin, and four underlie resistance to
doxorubicin. The number of genetic determinants that
underlie resistance fell within this range (1–4) for all 23
SMPs (Figure S4), although the quantitative nature of
these traits makes it difficult to predict the exact number
of determinants. Although ‘‘off-target’’ effects could
confound the true breadth of this range, many of the
SMPs are natural products (e.g., rapamycin) that display
known fine specificity for their molecular targets. In-
deed, our results are consistent with previous studies,
which found that multiple heterozygous whole-gene
deletion strains are haploinsufficient in response to per-
turbation by a small molecule [16].
After establishing that sensitivity or resistance to
a small molecule can be a complex trait, we addressed
whether the same genetic determinants were responsi-
ble for resistance to all SMPs (i.e., a nonspecific multi-
drug efflux effect), or whether a unique set of genes se-
lectively confers resistance to each SMP (i.e., random
segregation and independent assortment of distinct
Chemistry & Biology
322Figure 3. Dimensionality Reduction by 2D HAC Demonstrates Random and Independent Assortment of Genetic Determinants Underlying Re-
sistance or Sensitivity to Each SMP
(A) 2D clustergram of a 314 3 23 matrix; each column is a small molecule; each row is a segregant; red indicates saturating growth, or resis-
tance; green indicates no growth, or sensitivity.
(B) Small-molecule complex trait profiles of S1029 (‘‘S’’), XHS123 (‘‘X’’), YAG040 (‘‘Y’’), and two XHS123 segregants, D11 and C01, possess
sensitivity profiles that are highly similar to that of YAG040. From left to right, identity of SMPs are: SMP17, SMP7, SMP48, SMP21,
SMP49, SMP16, SMP45, SMP13, SMP10, SMP11, SMP30, SMP36, SMP3, SMP22, CSM-URA, G418, SMP2, SMP9, SMP50, SMP5, SMP33,
SMP38, and SMP51.
(C) Venn diagram depicting phenotypic linkage and antilinkage. The large number in the red circle indicates how many segregants are resistant to
50 mg/ml flunarizine (SMP9), in the blue circle indicates how many segregants are resistant to 25 mg/ml FCCP (SMP21), and in the green circle in-
dicates how many segregants are resistant to 25 mg/ml calcimycin (SMP2). The small numbers in the overlapping region correspond to the ob-
served number of coresistant segregants, while the numbers in parentheses correspond to the expected number of coresistant segregants.
The significance of overlaps (p value, hypergeometric distribution) between SMP9 resistance and SMP21 resistance (red and blue), SMP9 resis-
tance and SMP2 resistance (red and green), and SMP21 resistance and SMP2 resistance (blue and green) are indicated with arrows.genetic determinants that underlie resistance or sensi-
tivity to each SMP). Several key observations affirm
the latter. First, we observed unlinked segregation of re-
sistance to flunarizine and to G418 (Figure 1C) in the
314-member library of segregants, as well as in tetrad
dissections. Second, as shown in Figure 3A, red (resis-
tant) and green (sensitive) slashes, which correspond
to the growth of individual segregants in various
SMPs, are generally randomly distributed in the cluster-
gram that was generated by two-dimensional hierarchi-
cal agglomerative clustering (2D-HAC), a method of
dimensionality reduction. The segregation of the URA3::
kanMX4 control Mendelian locus largely defines the
overall structure of the clustergram.In order to illustrate random segregation and indepen-
dent assortment more clearly, we compared the resis-
tance/sensitivity profiles of the parental and hybrids
and several similar segregants. The parental and hybrid
responses to nearly all of the 23 SMPs differed, as
shown in Figure 3B and in Figure S1. Remarkably, how-
ever, there were instances where recombination pre-
served the parental and hybrid resistances and/or sensi-
tivities, except at one or a few positions (Figure 3B). For
example, one of the two segregants whose resistance/
sensitivity profile is similar to that of YAG040, C01, in-
herited resistance to tunicamycin, an inhibitor of protein
glycosylation [17], while the other, D11, did not (Fig-
ure 3B). This result is true for the majority of SMPs,
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323Figure 4. Principal Component Analysis Ren-
ders a 3D Chemical Space of SMPs that Illus-
trates the Notion of Functional Analogs
(A) 2D projection of a 3D PCA chemical
space whose axes correspond to the first
three principal components (F1, F2, and
F3). Tacks represent SMPs; green tacks are
labeled by corresponding SMP names; as-
terisked tacks represent SMPs that are mod-
ulators of Ca2+ homeostasis.
(B) Structures of a group of modulators of
Ca2+ homeostasis: penitrem A (SMP50);
amiodarone (SMP17); flunarizine (SMP9);
curcumin (SMP5); calcimycin (SMP2).suggesting that a unique set of genetic determinants se-
lectively confers resistance to each SMP.
Next, we examined the SMPs for which the underlying
genetic determinants of resistance or sensitivity ap-
peared to be the same. We used principal component
analysis (PCA), another method of dimensionality reduc-
tion, in order to render a three-dimensional (3D) ‘‘chem-
ical space’’ of SMPs (Figure 4A). We observe clusters of
SMPs that have been described previously as targeting
the same proteins or pathways in cells (‘‘functional ana-
logs’’); for comparison, G418 and CSM-URA, which are
completely orthogonal to each other, reside in opposite
corners of chemical space.
One cluster consists of flunarizine, amiodarone [18]
(SMP17), calcimycin [19] (SMP2), curcumin [20]
(SMP5), and penitrem A [21] (SMP50), all structurally dis-
similar modulators of calcium ion homeostasis (Fig-
ure 4B). A second cluster consists of two known and
two putative modulators of respiratory metabolism, re-
spectively: menadione [22] (SMP30) and carbonyl cya-
nide 4-trifluoromethoxy-phenylhydrazone [23] (FCCP)
(SMP21); and LY83583 [24] (SMP11) and 1,9-pyrazo-
loanthrone [25] (SMP10). A third cluster contains two
structurally different antagonists of a master regulatorof Ca2+-mediated signaling, calmodulin CMD1: chlor-
promazine [26] and E6-berbamine [27]. Overall, our re-
sults suggest that this method also enables insights
into mechanisms of small molecules, since small mole-
cules with unknown mechanisms of action can be
grouped together with those having known mecha-
nisms.
We determined the degree of linkage between func-
tional analogs on the basis of a probability test (p value,
hypergeometric distribution) between pairs of traits. We
observed significant (phenotypic) linkage between
SMPs in each of the three aforementioned clusters of
functional analogs. On the other hand, two blocs of re-
sistance stand out as antilinked: dominant resistance
to three compounds—FCCP (SMP21), LY83583 (SMP11),
and 1,9-pyrazoloanthrone (SMP10)—that affect respira-
tory metabolism that may be encoded by YAG040-
derived determinants; and recessive resistance to two
compounds—calcimycin (SMP2) and flunarizine
(SMP9)—that affect Ca2+ homeostasis that may be en-
coded by S288c-derived loci (Figure 3B). Antilinkage
may occur when the same genetic determinant confers
the opposite effect on two different SMPs. We are un-
aware of anything about Ca2+ homeostasis in the
Chemistry & Biology
324Figure 5. Genetic Mapping Confirms the Complex and Kinetic Nature of the Response to Small Molecules in a Population of 104 Naturally
Recombinant Yeast Strains
LOD score is depicted on the y axis; the centers of yeast chromosomes (CHRI-XVI) are depicted as ticks on the x axis; asterisks denote linkage
peaks.
(A) Linkage of chromosomal intervals on CHRXIII (peak at base pair 27,644) and CHRXV (peak at base pair 250,452) to the resistance to 5 mg/ml
SMP21 at 40 hr postinoculation.
(B) Linkage of chromosomal intervals on CHRXIV (peak at base pair 476,445) and CHRXV (peak at base pair 250,452) to the resistance to
5 mg/ml SMP21 at 64 hr post inoculation.
(C) Linkage of chromosomal intervals on CHRVI (peak at base pair 183,351), CHRXIV (peak at base pair 472,845), and CHRXV (peak at base pair
250,452) to the resistance to 5 mg/ml SMP21 at 74 hr postinoculation.
(D) Linkage of a single chromosomal interval on CHRXV (peak at base pair 249,552) to the resistance to 6.7 mg/ml SMP11 at 40 hr post-
inoculation.
(E) Linkage of a single chromosomal interval on CHRXV (peak at base pair 250,452) to the resistance to 6.7 mg/ml SMP11 at 48 hr post-
inoculation.YAG040 background that can explain its sensitivity, and
vice versa, for S1029. However, S1029, as an S288c-
derived strain, harbors a mutation in the gene HAP1,
which results in constitutively low levels of cytochrome
c [28], while YAG040 encodes the wild-type copy of
HAP1. The sensitivity of S1029 to modulators of respira-
tory metabolism is consistent with it having a fragile re-
spiratory apparatus.
A total of 34 segregants are resistant to FCCP
(SMP21), 144 are resistant to flunarizine (SMP9), but
only 4 (1%) are coresistant to both (p = 3.5 3 1024; hy-
pergeometric distribution) when 16 (5%) are expected
by chance (Figure 3C). Moreover, dually resistant segre-
gants treated simultaneously with both FCCP and flu-
narizine failed to grow even though they grew in the
presence of each SMP alone, indicating that simulta-
neous small-molecule perturbation of Ca2+ homeostasis
and respiratory processes results in synthetic lethality
(Figure S5). Synthetic lethality between two SMPs may
be the result of phenotypic antilinkage if a genetic deter-
minant that confers resistance to flunarizine sensitizes
yeast cells to FCCP, and vice versa. This codependence
of Ca2+ homeostasis and respiratory processes is vali-
dated by extensive literature that documents the depen-
dence of mitochondrial function on calcium [29], al-
though no links have been drawn between these two
functional processes by natural genetic variation in
yeast.We confirmed that the response to small molecules is
indeed complex and kinetic, as well as the generality of
our approach, by mapping the chromosomal regions
that contain the genetic determinants underlying resis-
tance to two SMPs in a cross between the S288c labora-
tory strain and a different natural isolate, RM11. Specif-
ically, we tested for linkage over several time points
between resistance to two functional analogs that affect
respiratory processes, LY83583 (SMP11) and FCCP
(SMP21), and genetic markers in 104 previously geno-
typed segregants derived from a cross between
BY4716 (isogenic to S288c) and RM11-1a, an agricul-
tural isolate [30, 31].
Linkage was tested at three time points in the case of
SMP21—early, intermediate, and late—and two time
points in the case of SMP11—early and intermediate.
We report the results in terms of logarithm of odds
(LOD) scores. We assessed significance via 100 permu-
tations for each compound and time point, and consid-
ered LOD scores higher than any seen in the 100 permu-
tations for that compound and time point as highly
significant (genome-wide empirical p = 0.01), and those
LOD scores exceeded in 5 or fewer of the 100 permuta-
tions as significant (genome-wide empirical p = 0.05).
LOD scores above 3 but not significant by these criteria
were considered suggestive of linkage.
At the early time point, we observed a highly signifi-
cant linkage of SMP21 resistance to a quantitative trait
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325locus (QTL) spanning less than 1 kb on the left arm of
chromosome 13 (LOD score = 4.7) and a weaker, sug-
gestive linkage to a QTL spanning around 30 kb on the
left arm of chromosome 15 (LOD score = 3.0). The
weak QTL on chromosome 15 links more strongly at
later time points, with highly significant LOD scores of
6.8 and 8.1 at the intermediate and late time points, re-
spectively. At the intermediate time point, we observed
another suggestive linkage (LOD score = 3.6) to a QTL
spanning approximately 50 kb on the left arm of chromo-
some 14, and this linkage became highly significant at
the late time point (LOD score = 6.9). At the late time
point, we observed another suggestive linkage to a
QTL spanning 25 kb on the right arm of chromosome 6
(Figures 5A–5C). In total, we observed three highly sig-
nificant and one suggestive QTL linked to the response
to SMP21. The QTL on the left arm of chromosome 15
that links to SMP21 also links to resistance to SMP11
as a 10 kb interval, with highly significant LOD scores
of 5.7 and 8.3 at the early and intermediate time points,
respectively (Figures 5D and 5E), thus providing direct
genetic evidence that SMP11 and SMP21 are functional
analogs, and further increasing our confidence in the
linkages. Interestingly, none of the QTLs contains genes
known to be involved in the response to xenobiotics.
Furthermore, as our linkage analysis removes QTLs
that link to growth in the DMSO control condition, we
rule out the role of intrinsic differences in growth rates
among the 104 segregants as a contributing factor in
the response to either compound.
Significance
This work illustrates a general, scalable, low-cost,
chemical-genetic method for revealing complex traits
in budding yeast. Cumulatively, the SMPswe usedper-
turb a wide swath of cellular processes, but, individu-
ally, the genes with which they interact are distinct, ex-
cept in the case of functional analogs whose common
reported mechanisms of action we validated. The
extensive characterization of natural genetic variation
with small molecules complements the use of de
novo or artificial mutations in a fixed genetic back-
ground, since most naturally occurring mutations are
not neat excisions of open reading frames. The sys-
tematic combination of natural variants of yeast and
small molecules that modulate evolutionarily con-
served cellular processes may have several applica-
tions: (1) as a small-molecule classifier—used to iden-
tify mechanisms of action of small molecules; (2) the
classification and characterization of genetic traits
(Mendelian versus complex); and (3) the systematic




Parental diploid strains S1029, an S288c derivative (MATa/MAT-
alpha gal2/gal2 hoD::natMX4/hoD::natMX4), and YAG040 (HO/hoD::
hphMX4 MATa/MATalpha), along with F1 hybrid strain XHS123
(URA3/ura3D::kanMX4), were generous gifts from John H.
McCusker, Duke University, Durham, NC. A total of 104 genotyped
segregants from the BY4716/RM11-1a cross were previously de-
scribed [30]. The kanMX resistance cassette encodes a phospho-transferase that confers resistance to the aminoglycoside G418 (ge-
neticin) while replacing the S288c-derived copy of URA3, a gene
involved in uracil biosynthesis; the hphMX resistance cassette en-
codes a phosphotransferase that confers resistance to the amino-
glycoside hygromycin B while replacing one copy of the HO gene,
the endonuclease responsible for mating-type switching. XHS123
is HO/ho, which means that we expect approximately 50% of segre-
gants to be haploid (ho) and 50% to be diploid (HO) as a result of self-
diploidization. We find no significant effect of ploidy on growth,
except a subtle growth advantage to homozygous diploid recombi-
nants that is undetectable by the 48 hr time point. For added
stringency, we considered 375 MATa haploid segregants in our es-
timation of polygenic degree on the basis of sensitivity to the mating
pheromone a factor.
Natural Recombinant Yeast Library Generation
Culturing and sporulation of yeast as well as media formulation was
done as previously described [33]. XHS123 segregants were derived
as random spores (not by tetrad dissection). They were manually ar-
rayed from dabs of single colonies grown on agar plates into individ-
ual wells of 384-well plates containing rich media to make strain
stock plates. NUNC 384-well, clear-bottom, untreated, sterile plates
(VWR, no. 62409-604) containing rich media and either vehicle sol-
vent (dimethyl sulfoxide [DMSO]) or a given SMP were inoculated
with yeast from strain stock plates using sterile polypropylene
384-pin replicators (Genetix, no. X5050). Inoculated plates were
grown without agitation on the benchtop at ambient temperature
conditions for 48–72 hr, and then vortexed on a standard tabletop
vortexer (VWR) for 10–30 s prior to measurement in a SpectraMax
plate reader (Molecular Devices) set to 600 nm emission. The growth
of each XHS123 segregant in rich media containing a given SMP was
compared to its growth in media containing DMSO. We used the re-
ciprocal segregation of the kanMX and URA3 markers as a positive
indicator of recombination, and discarded products of sporulation
that were neither G418SEN/URA+ nor G418RES/URA2. We arrived at
314 segregants in the smaller library because at least 314 of 380
(83%) products of sporulation passed the recombination test. We
arrived at 1932 segregants (375 of which are MATa, as assessed
by sensitivity to the mating pheromone a factor) in the larger library
because at least 1932 of 2944 (66%) products of sporulation passed
the recombination test. The discarded products of sporulation are
either extremely slow-growing segregants or contaminating diploids
(G418RES/URA+). Cut-offs of resistance and sensitivity were visually
assessed with the rank-ordered distributions of the segregants
grown in the presence of each SMP.
SMPs
SMPs were individually purchased as powder stocks from various
vendors in either 10 mg or smaller quantities, and then resuspended
in DMSO in glass vials as stock solutions: calcimycin (Biomol, no.
CA-100); E6-berbamine (Biomol, no. CA-302); curcumin (Biomol,
no. EI-135); doxorubicin (Biomol, no. GR-319); flunarizine (Biomol,
no. CA-225); 1,9-pyrazoloanthrone (EMD Biosciences, no. 420119);
LY83583 (Biomol, no. CN-200); tunicamycin (Biomol, no. CC-104),
anisomycin (Biomol, no. ST-102); amiodarone (Biomol, AC-105);
FCCP (Sigma-Aldrich, no. C2920); chlorpromazine (EMD Biosci-
ences, no. 215921); menadione (Sigma-Aldrich, no. M5625); pimo-
zide (Tocris, no. 0937); diphenyleneiodonium (Sigma-Aldrich, no.
D2926); spermine NONOate (EMD Biosciences, no. 567703); rapa-
mycin (EMD Biosciences, no. 553210); manumycin (Biomol, no.
G-236); mastoparan (EMD Biosciences, no. 444898); penitrem A
(Biomol, no. KC-157); wortmannin (EMD Biosciences, no. 681675).
See the NCI-sponsored public database ChemBank (http://
chembank.med.harvard.edu) for complete structural annotations
and mechanisms of action.
Computational Dimensionality Reduction
Duplicate measurements were averaged and arranged in a matrix, S,
as shown in Figure 1A, consisting of an ordered array of rows and
columns. Each row (xi, where i = 1 to m) corresponds to growth of
a particular segregant across the set of SMPs; each column (yj,
where j = 1 to n) corresponds to a particular SMP. Accordingly, an
element (xm, yn) of S encodes information about segregant m for
phenotypic descriptor n. 2D-HAC and p values based on the
Chemistry & Biology
326hypergeometric distribution were computed using XLSTAT-Pro7.1
(Addingsoft) in Microsoft Excel; PCA and data visualization was per-
formed by Spotfire DecisionSite v.7.0 (Spotfire, Inc.).
Linkage Analysis
All linkage analysis was performed using the R/Qtl software package
[34], and significance was assessed via permutations. The analysis
was done using a set of 104 segregants and 2972 markers. Pheno-
types and genotypes were arranged into the proper csv file format
for direct input into R/Qtl. Phenotypes (responses to small mole-
cules) were scanned under the default (normal) single QTL model us-
ing the standard EM algorithm. All control (DMSO-treated) pheno-
types were used as additive covariates in order to eliminate their
effect on linkage.
Supplemental Data
Supplemental Data, including a table and figures, are available online
at http://www.chembiol.com/cgi/content/full/13/3/319/DC1/.
Acknowledgments
We thank J.H. McCusker for yeast strains; the staff of the Broad In-
stitute Chemical Biology Program (formerly the Institute for Chemis-
try and Chemical Biology) for technical assistance; E.S. Lander, D.
Altshuler, and A.L. Perlstein for comments and discussion. This
work was supported by the National Institute of General Medicine
Sciences (S.L.S.) and the National Institute of Mental Health (L.K.).
L.K. is a James S. McDonnell Centennial Fellow. S.L.S. is an Investi-
gator at the Howard Hughes Medical Institute lab located in the De-
partment of Chemistry and Chemical Biology, Harvard University.
Received: April 11, 2005
Revised: January 13, 2006
Accepted: January 20, 2006
Published online: March 24, 2006
References
1. Forsburg, S.L. (2001). The art and design of genetic screens:
yeast. Nat. Rev. Genet. 2, 659–668.
2. Tong, A.H., and Boone, C. (2005). Synthetic genetic array analy-
sis Saccharomyces cerevisiae. Methods Mol. Biol. 313, 171–
192.
3. Abiola, O., Angel, J.M., Avner, P., Bachmanov, A.A., Belknap,
J.K., Bennett, B., Blankenhorn, E.P., Blizard, D.A., Bolivar, V.,
Brockmann, G.A., et al. (2003). The nature and identification of
quantitative trait loci: a community’s view. Nat. Rev. Genet. 4,
911–916.
4. Anholt, R.R.H., and Mackay, T.F.C. (2004). Quantitative genetic
analyses of complex behaviours in Drosophila. Nat. Rev. Genet.
5, 838–849.
5. Arnold, P.D., Zai, G., and Richter, M.A. (2004). Genetics of anxi-
ety disorders. Curr. Psychiatry Rep. 6, 243–254.
6. Parsons, A.B., Brost, R.L., Ding, H., Li, Z., Zhang, C., Sheikh, B.,
Brown, G.W., Kane, P.M., Hughes, T.R., and Boone, C. (2004). In-
tegration of chemical-genetic and genetic interaction data links
bioactive compounds to cellular target pathways. Nat. Biotech-
nol. 22, 62–69.
7. Giaever, G., Flaherty, P., Kumm, J., Proctor, M., Nislow, C., Jar-
amillo, D.F., Chu, A.M., Jordan, M.I., Arkin, A.P., and Davis, R.W.
(2004). Chemogenomic profiling: identifying the functional inter-
actions of small molecules in yeast. Proc. Natl. Acad. Sci. USA
101, 793–798.
8. Beadle, G.W., and Tatum, E.L. (1941). Genetic control of bio-
chemical reactions in Neurospora. Proc. Natl. Acad. Sci. USA
27, 499–506.
9. Brem, R.B., Yvert, G., Clinton, R., and Kruglyak, L. (2002). Ge-
netic dissection of transcriptional regulation in budding yeast.
Science 296, 752–755.
10. Yvert, G., Brem, R.B., Whittle, J., Akey, J.M., Foss, E., Smith,
E.N., Mackelprang, R., and Kruglyak, L. (2003). Trans-acting reg-
ulatory variation in Saccharomyces cerevisiae and the role of
transcription factors. Nat. Genet. 35, 57–64.11. Marullo, P., Bely, M., Masneuf-Pomarede, I., Aigle, M., and
Dubourdieu, D. (2004). Inheritable nature of enological quantita-
tive traits is demonstrated by meiotic segregation of industrial
wine yeast strains. FEM. Yeast Res. 4, 711–719.
12. Deutschbauer, A.M., and Davis, R.W. (2005). Quantitative trait
loci mapped to single-nucleotide resolution in yeast. Nat. Genet.
37, 1333–1340.
13. Steinmetz, L.M., Sinha, H., Richards, D.R., Spiegelman, J.I., Oef-
ner, P.J., McCusker, J.H., and Davis, R.W. (2002). Dissecting the
architecture of a quantitative trait locus in yeast. Nature 416,
326–330.
14. Gu, Z., David, L., Petrov, D., Jones, T., Davis, R.W., and Stein-
metz, L.M. (2005). Elevated evolutionary rates in the laboratory
strain of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA
102, 1092–1097.
15. Amery, W.K. (1983). Flunarizine, a calcium channel blocker:
a new prophylactic drug in migraine. Headache 23, 70–74.
16. Lum, P.Y., Armour, C.D., Stepaniants, S.B., Cavet, G., Wolf,
M.K., Butler, J.S., Hinshaw, J.C., Garnier, P., Prestwich, G.D.,
Leonardson, A., et al. (2004). Discovering modes of action for
therapeutic compounds using a genome-wide screen of yeast
heterozygotes. Cell 116, 121–137.
17. Elbein, A.D. (1984). Inhibitors of the biosynthesis and processing
of N-linked oligosaccharides. CRC Crit. Rev. Biochem. 16, 21–
49.
18. Pozniakovsky, A.I., Knorre, D.A., Markova, O.V., Hyman, A.A.,
Skulachev, V.P., and Severin, F.F. (2005). Role of mitochondria
in the pheromone- and amiodarone-induced programmed death
of yeast. J. Cell Biol. 168, 257–269.
19. Gruetter, C.A., Lemke, S.M., Valentovic, M.A., and Szarek, J.L.
(1994). Evidence that histamine is involved as a mediator of en-
dothelium-dependent contraction induced by A23187 in bovine
intrapulmonary vein. Eur. J. Pharmacol. 257, 275–283.
20. Logan-Smith, M.J., Lockyer, P.J., East, J.M., and Lee, A.G.
(2001). Curcumin, a molecule that inhibits the Ca2+-ATPase of
sarcoplasmic reticulum but increases the rate of accumulation
of Ca2+. J. Biol. Chem. 276, 46905–46911.
21. Knaus, H.G., McManus, O.B., Lee, S.H., Schmalhofer, W.A.,
Garcia-Calvo, M., Helms, L.M., Sanchez, M., Giangiacomo, K.,
Reuben, J.P., Smith, A.B., III, et al. (1994). Tremorgenic indole
alkaloids potently inhibit smooth muscle high-conductance
calcium-activated potassium channels. Biochemistry 33,
5819–5828.
22. Shapira, M., Segal, E., and Botstein, D. (2004). Disruption of
yeast forkhead-associated cell cycle transcription by oxidative
stress. Mol. Biol. Cell 15, 5659–5669.
23. Heytler, P.G., and Prichard, W.W. (1962). A new class of uncou-
pling agents—carbonyl cyanide phenylhydrazones. Biochem.
Biophys. Res. Commun. 7, 272–275.
24. Lodygin, D., Menssen, A., and Hermeking, H. (2002). Induction of
the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation
in a p53-independent manner. J. Clin. Invest. 110, 1717–1727.
25. Shin, M., Yan, C., and Boyd, D. (2002). An inhibitor of c-jun
aminoterminal kinase (SP600125) represses c-Jun activation,
DNA-binding and PMA-inducible 92-kDa type IV collagenase ex-
pression. Biochim. Biophys. Acta 1589, 311–316.
26. Wiley, J.S., and McCulloch, K.E. (1982). Calcium ions, drug ac-
tion and the red cell membrane. Pharmacol. Ther. 18, 271–292.
27. Zhu, H.J., and Liu, G.Q. (2003). Effect of E6, a novel calmodulin
inhibitor, on activity of P-glycoprotein in purified primary cul-
tured rat brain microvessel endothelial cells. Acta Pharmacol.
Sin. 24, 1143–1149.
28. Gaisne, M., Becam, A.M., Verdiere, J., and Herbert, C.J. (1999). A
‘natural’ mutation in Saccharomyces cerevisiae strains derived
from S288c affects the complex regulatory gene HAP1 (CYP1).
Curr. Genet. 36, 195–200.
29. Gunter, T.E., Yule, D.I., Gunter, K.K., Eliseev, R.A., and Salter,
J.D. (2004). Calcium and mitochondria. FEBS Lett. 567, 96–102.
30. Brem, R.B., and Kruglyak, L. (2005). The landscape of genetic
complexity across 5,700 gene expression traits in yeast. Proc.
Natl. Acad. Sci. USA 102, 1572–1577.
31. Mortimer, R.K., Romano, P., Suzzi, G., and Polsinelli, M. (1994).
Genome renewal: a new phenomenon revealed from a genetic
Revealing Complex Traits with Small Molecules
327study of 43 strains of Saccharomyces cerevisiae derived from
natural fermentation of grape musts. Yeast 10, 1543–1552.
32. Freimer, N., and Sabatti, C. (2003). The human phenome project.
Nat. Genet. 34, 15–21.
33. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman,
J.G., Smith, J.A., and Struhl, K., eds. (1996). Current Protocols in
Molecular Biology, Volume 2 (New York: John Wiley and Sons).
34. Broman, K.W., Wu, H., Sen, S., and Churchill, G.A. (2003). R/qtl:
QTL mapping in experimental crosses. Bioinformatics 19, 889–
890.
